May 30, 2025
110:101
For every 101 shares held, investors received 110. The price per share adjusted from $4305.00 to $3952.77.
The split itself did not change the total investment value.
Bukwang Pharmaceutical Co., Ltd. (KRX:003000) operates in the Pharmaceuticals: major industry.
Bukwang Pharmaceutical Co., Ltd. company overviewBukwang Pharmaceutical Co., Ltd.'s most recent stock split was on May 30, 2025. It was a 110-for-101 forward split, so shareholders received 110 shares for every 101 they held.
Bukwang Pharmaceutical Co., Ltd. (KRX:003000) has split its stock 14 times: a 11-for-10 split on September 24, 2004, a 21-for-20 split on March 29, 2007, a 21-for-20 split on March 28, 2008, a 21-for-20 split on December 28, 2011, a 21-for-20 split on December 27, 2012, a 21-for-20 split on December 27, 2013, a 11-for-10 split on December 29, 2014, a 11-for-10 split on December 29, 2015, a 6-for-5 split on December 28, 2016, a 11-for-10 split on December 27, 2017, a 13-for-10 split on December 27, 2018, a 21-for-20 split on December 27, 2019, a 11-for-10 split on December 29, 2020, and a 110-for-101 split on May 30, 2025.
Bukwang Pharmaceutical Co., Ltd. has split its stock 14 times. This history records 14 forward splits between September 24, 2004 and May 30, 2025.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Bukwang Pharmaceutical Co., Ltd.'s 110-for-101 split on May 30, 2025, every 101 shares became 110 shares.
Bukwang Pharmaceutical Co., Ltd. has not announced a new split in our records. Its most recent split was on May 30, 2025, 1 year ago. Companies announce splits in advance, and any new KRX:003000 split will appear on this page.
Already premium?